[HTML][HTML] A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes

T Sanderson, R Hisner, I Donovan-Banfield, H Hartman… - Nature, 2023 - nature.com
Molnupiravir, an antiviral medication widely used against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), acts by inducing mutations in the virus genome during …

[HTML][HTML] A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes

T Sanderson, R Hisner, H Hartman, A Løchen… - Nature, 2023 - ncbi.nlm.nih.gov
Molnupiravir, an antiviral medication widely used against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), acts by inducing mutations in the virus genome during …

A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes

T Sanderson, R Hisner, H Hartman, A Løchen… - Nature, 2023 - ideas.repec.org
Molnupiravir, an antiviral medication widely used against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), acts by inducing mutations in the virus genome during …

A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes

T Sanderson, R Hisner, H Hartman, A Løchen… - …, 2023 - researchportal.ukhsa.gov.uk
Molnupiravir, an antiviral medication widely used against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), acts by inducing mutations in the virus genome during …

A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes

T Sanderson, R Hisner, H Hartman, A Løchen… - Nature, 2023 - econpapers.repec.org
Molnupiravir, an antiviral medication widely used against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), acts by inducing mutations in the virus genome during …

A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes

T Sanderson, R Hisner, H Hartman, A Løchen… - …, 2023 - ui.adsabs.harvard.edu
Molnupiravir, an antiviral medication widely used against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), acts by inducing mutations in the virus genome during …

A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes

T Sanderson, R Hisner, H Hartman, A Løchen… - 2023 - repository.cam.ac.uk
Molnupiravir, an antiviral medication widely used against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), acts by inducing mutations in the virus genome during …

A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes

T Sanderson, R Hisner, H Hartman, A Løchen… - 2023 - crick.figshare.com
Molnupiravir, an antiviral medication that has been widely used against SARS-CoV-2, acts
by inducing mutations in the virus genome during replication. Most random mutations are …

A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes

T Sanderson, R Hisner, H Hartman, A Løchen… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Molnupiravir, an antiviral medication widely used against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), acts by inducing mutations in the virus genome during …

Identification of a molnupiravir-associated mutational signature in SARS-CoV-2 sequencing databases

T Sanderson, R Hisner, I Donovan-Banfield, H Hartman… - medRxiv, 2023 - medrxiv.org
Molnupiravir, an antiviral medication that has been widely used against SARS-CoV-2, acts
by inducing mutations in the virus genome during replication. Most random mutations are …